http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110286162-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2030-062
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2030-027
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-06
filingDate 2019-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2022-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-110286162-B
titleOfInvention A kind of determination method of dissolution rate of pharmaceutical preparation containing paracetamol, dextromethorphan hydrobromide and doxylamine succinate
abstract The invention discloses a method for determining the dissolution rate of a pharmaceutical preparation containing paracetamol, dextromethorphan hydrobromide and doxylamine succinate. The steps are as follows: (1) The pharmaceutical preparations of dextromethorphan and doxylamine succinate are added to the dissolution medium for dissolution treatment, sampling and filtration to obtain a dissolution liquid; (2) Detecting paracetamol, dextromethorphan hydrobromide and succinate in the dissolution liquid content of doxylamine acid; (3) determining the dissolution rate of the pharmaceutical preparation according to the detection result of step (2). The invention can effectively simulate the dissolution behavior in vivo in vitro, determine the dissolution rate of soft capsules containing paracetamol, dextromethorphan hydrobromide and doxylamine succinate, and provide technical support for drug research and development and quality control . The invention can simultaneously measure the dissolution results of the three substances under the same condition, greatly saves the detection time and the detection cost, and has good accuracy and reproducibility.
priorityDate 2019-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11224
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6342
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516951
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449122806
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557597
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452794758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559502
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450723585
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462351
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62657
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450177930
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1983

Total number of triples: 30.